Home

Centre for Cancer Biomarkers CCBIO

Biomarkers and bioinformatics meeting

Biomarkers & Bioinformatics in Clinical Trials and Clinical Studies

Dear CCBIO members, CCBIO associates, and researchers focusing on biomarker detection through use of patient material and advanced bioinformatics tools. We have the pleasure of inviting you to: Biomarkers & Bioinformatics in Clinical Trials and Clinical Studies Symposium, June 18th-19th 2017 at Solstrand Hotel.

We have brought together speakers with an in-depth knowledge and experience within essential areas of biomarker identification, sharing how they work with clinical samples and bioinformatics in the search for specific biomarkers for a disease or treatment response.

There will also be ample time for interaction between the participants during this meeting. The symposium is open for all, so please feel free to circulate this invitation.

Participants, particularly PhD and MSc students, are encouraged to bring a poster on their work. No abstract required. 

Scientific program

SUNDAY 18. June

13.30‐14.15Arrival and registration 
14.15‐14.30WelcomeSonia
Gavasso
14.30­‐15.15The role of bioinformatics and clinical trials in the
discovery of biomarkers
Ola
Myklebost
15.15-15.40Break 
 Working with complex data 
15.40-16.05Genomics: how to select the right approach to identify
true biomarkers
Leonardo
Meza-Zepeda
16.05-16.30The key role of proteomics in biomarker discoveryHarald
Barsnes
16.30-16.55Novel approach for extracting information from
experiments with multiple input factors
Ellen
Mosleth
16.55-17.15Break 
17.15-17.30Topological data analysisMorten
Brun
17.30-17.50Ultra-deep sequencing of mitochondrial DNA
in single cells
Gonzalo
Nido
17.50-18.10Integrated analysis of epigenomic and gene expressionEndre
Anderssen
19.30Dinner - Enjoy a culinary experience at Solstrand Hotel
& Bad with participants and  presenters
 

MONDAY 19. June

 Clinical trials 
09.00-09.30What are clinical trials?Nina
Jebsen
09.30-09.50Patient's view on clinical trialsPatient
09.50-10.10Break 
 Clinical trials for biomarker detection and evaluation 
- opportunities, benefits and challenges
 
10.10-10.30A clinician's viewChristian
Vedeler
10.30-10.50A molecular biologist's viewReidun
Kopperud
10.50-11.10The biostatistician's viewNello
Blaser
11.10-11.30The ethicist's viewRoger
Strand
11.30-12.30Lunch 
 Sample and data management 
12.30-12.45Biobank Haukeland, the research biobank at
Haukeland University Hospital
Ann Cathrine
Kroksveen
12.45-13.00Pubgene for management and interpretation of genomic dataRandi
Hovland
13.00-13.15CytBASEStein-­Erik
Gullaksen
13.15-13.45Big dataEirik
Thorsnes
13.45-14.10National services offered by Elixir Norway for non-sensitive and sensitive molecular Life Science data: NeLS and TSDKjell
Petersen
14.10-14.30Break 
 Clinical mass cytometry 
14.30-14.50A practical example: A cross-­sectional study for disease mechanisms in rheumatoid arthritisLucius
Bader
14.50-15.10Antibody monitoring in multiple sclerosisGerd
Bringeland
15.10-15.30An analytical approach: Are there any biomarker relevant molecular changes out there?Jørn
Skavland
15.30-15.45Centre for Digital Life Norway - Opportunities for multidisciplinary research and innovationRune
Kleppe
15.45-15.55Closing remarksEllen Mostleth and Sonia Gavasso

See attachment below for printer friendly program.